Select Publications
Journal articles
2010, 'Event rates, hospital utilization, and costs associated with major complications of diabetes: A multicountry comparative analysis', PLoS Medicine, 7, http://dx.doi.org/10.1371/journal.pmed.1000236
,2010, 'The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia-pacific region: The obesity in Asia collaboration', Obesity Reviews, 11, pp. 127 - 136, http://dx.doi.org/10.1111/j.1467-789X.2009.00605.x
,2010, 'Cardiovascular outcomes in type 2 diabetes: The impact of preventative therapies', Annals of the New York Academy of Sciences, 1212, pp. 29 - 40, http://dx.doi.org/10.1111/j.1749-6632.2010.05837.x
,2010, 'Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis', The Lancet, 375, pp. 1875 - 1884, http://dx.doi.org/10.1016/S0140-6736(10)60656-3
,2010, 'Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial', Journal of Hypertension, 28, pp. 1141 - 1149, http://dx.doi.org/10.1097/HJH.0b013e328338a89c
,2010, 'Intensive glucose control and macrovascular outcomes in type 2 diabetes. Reply to Emanuele NV [letter] and Yudkin JS, Richter B [letter]', DIABETOLOGIA, 53, pp. 218 - 218, http://dx.doi.org/10.1007/s00125-009-1565-7
2010, 'HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY', Value in Health, 13, pp. A504 - A504, http://dx.doi.org/10.1016/s1098-3015(11)73064-9
,2009, 'Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy', Annals of Internal Medicine, 151, pp. 631 - 638, http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00008
,2009, 'Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial', Diabetologia, 52, pp. 2328 - 2336, http://dx.doi.org/10.1007/s00125-009-1484-7
,2009, 'Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial', Diabetes Care, 32, pp. 2068 - 2074, http://dx.doi.org/10.2337/dc09-0959
,2009, 'Intensive glucose control and macrovascular outcomes in type 2 diabetes', Diabetologia, 52, pp. 2288 - 2298, http://dx.doi.org/10.1007/s00125-009-1470-0
,2009, 'Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: A randomised controlled trial', Diabetologia, 52, pp. 2027 - 2036, http://dx.doi.org/10.1007/s00125-009-1457-x
,2009, 'Cardiovascular Risk in Type 2 Diabetes—Reflecting on the ADVANCE Study', US Cardiology Review, 6, pp. 46 - 50, http://dx.doi.org/10.15420/usc.2009.6.2.46
,2009, 'Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: Findings from the Kanyini Audit', Medical Journal of Australia, 191, pp. 304 - 309, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02811.x
,2009, 'Gaps in cardiovascular disease risk management in Australian general practice', Medical Journal of Australia, 191, pp. 324 - 329, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02816.x
,2009, 'Routine blood pressure lowering and intensive glucose control in patiens with type 2 diabetes: The ADVANCE trial', Expert Review of Endocrinology and Metabolism, 4, pp. 111 - 118, http://dx.doi.org/10.1586/17446651.4.2.111
,2009, 'Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes', Journal of the American Society of Nephrology, 20, pp. 1813 - 1821, http://dx.doi.org/10.1681/ASN.2008121270
,2009, 'Trials of cardiovascular risk factor management in type 2 diabetes', Current Opinion in Cardiology, 24, pp. 288 - 294, http://dx.doi.org/10.1097/HCO.0b013e32832a7b01
,2009, 'Cardiovascular risk: Who should we treat, and how much should we stratify?', Heart, 95, pp. 783 - 784, http://dx.doi.org/10.1136/hrt.2008.148387
,2009, 'Recalibration of a Framingham risk equation for a rural population in India', Journal of Epidemiology and Community Health, 63, pp. 379 - 385, http://dx.doi.org/10.1136/jech.2008.077057
,2009, 'Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: Results of the ADVANCE study', European Heart Journal, 30, pp. 1128 - 1135, http://dx.doi.org/10.1093/eurheartj/ehp055
,2009, 'Cardiovascular risk assessment', Australian Doctor, pp. 25 - 32
,2009, 'Lowering blood pressure reduces renal events in type 2 diabetes', Journal of the American Society of Nephrology, 20, pp. 883 - 892, http://dx.doi.org/10.1681/ASN.2008070667
,2009, 'New perspectives in the treatment of the diabetic patient. ADVANCE Study', Hipertension y Riesgo Vascular, 26, pp. 80 - 83, http://dx.doi.org/10.1016/S1889-1837(09)71180-8
,2009, 'ADVANCE: Blood pressure lowering in diabetes', Journal of Clinical Hypertension, 11, pp. 108, http://dx.doi.org/10.1111/j.1751-7176.2008.00067_1.x
,2009, 'ADVANCE: Blood Pressure Lowering in Diabetes', JOURNAL OF CLINICAL HYPERTENSION, 11, pp. 108 - 108, http://dx.doi.org/10.1111/j.1751-7176.2008.00067_1.x
,2009, 'An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: Development and mixed methods evaluation', Journal of Medical Internet Research, 11, http://dx.doi.org/10.2196/jmir.1258
,2009, 'Cardiovascular risk in type 2 diabetes - Reflecting on the ADVANCE study', US Endocrinology, 5, pp. 95 - 99, http://dx.doi.org/10.17925/use.2009.05.1.42
,2009, 'Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study', American Heart Journal, 157, http://dx.doi.org/10.1016/j.ahj.2008.09.026
,2009, 'Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region.', Journal of diabetes, 1, pp. 173 - 181, http://dx.doi.org/10.1111/j.1753-0407.2009.00028.x
,2009, 'A novel electronic decision support system to assist General Practitioners in cardiovascular disease risk management—A pilot evaluation', Heart, Lung and Circulation, 18, pp. S269
,2009, 'Cardiovascular Risk in Type 2 Diabetes – Reflecting on the ADVANCE Study', European Endocrinology, 05, pp. 42 - 42, http://dx.doi.org/10.17925/ee.2009.05.00.42
,2009, 'Cardiovascular risk management among female and male patients in Australian General Practice: The AusHEART study', Heart, Lung and Circulation, 18, pp. S272
,2009, 'Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment', Heart, Lung and Circulation, 18, pp. S280
,2009, 'Framingham and UKPDS equations overestimate the risk of coronary events in a contemporary diabetic population', Heart, Lung and Circulation, 18, pp. S242 - S243, http://dx.doi.org/10.1016/j.hlc.2009.05.600
,2009, 'Management of cardiovascular risk factors in Australian general practice of those at highest risk', Australasian Epidemiologist
,2009, 'Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction', Heart, Lung and Circulation, 18, pp. S280 - S281
,2009, 'Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice', American Heart Journal, 157, pp. 436 - 441, http://dx.doi.org/10.1016/j.ahj.2008.11.016
,2008, 'Intensive glucose control did not prevent important complications in type 2 diabetes', Evidence-Based Medicine, 13, pp. 168 - 169, http://dx.doi.org/10.1136/ebm.13.6.168
,2008, 'Why is there more heat than light concerning the polypill?', BMJ (Clinical research ed.), 337, http://dx.doi.org/10.1136/bmj.a2162
,2008, 'Cardiovascular risk management at a Māori-led primary health organisation - Findings from a cross-sectional audit', New Zealand Medical Journal, 121
,2008, 'Why is there more heat than light concerning the polypill?', BMJ, 337, pp. 947 - 948
,2008, 'Dr. Patel and colleagues reply', New England Journal of Medicine, 359, pp. 1521
,2008, 'Intensive glucose control in type 2 diabetes - Reply', NEW ENGLAND JOURNAL OF MEDICINE, 359, pp. 1521 - 1521, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259631700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', PLoS Medicine, 5, pp. 1486 - 1495, http://dx.doi.org/10.1371/journal.pmed.0050207
,2008, 'Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes', New England Journal of Medicine, 358, pp. 2560 - 2572, http://dx.doi.org/10.1056/NEJMoa0802987
,2008, 'Prospective observational study of acute coronary syndromes in China: Practice patterns and outcomes', Heart, 94, pp. 554 - 560, http://dx.doi.org/10.1136/hrt.2007.119750
,2008, 'Retinal vascular lesions in patients of caucasian and asian origin with type 2 diabetes', Diabetes Care, 31, pp. 708 - 713, http://dx.doi.org/10.2337/dc07-1657
,2008, 'Body Mass Index is an Independent Determinant of Left Atrial Size', Heart Lung and Circulation, 17, pp. 19 - 24, http://dx.doi.org/10.1016/j.hlc.2007.04.006
,2008, 'The ADVANCE trial - Authors' reply', The Lancet, 371, pp. 26, http://dx.doi.org/10.1016/S0140-6736(08)60062-8
,